Amgen
AMGN
2,502 hedge funds and large institutions have $109B invested in Amgen in 2023 Q3 according to their latest regulatory filings, with 252 funds opening new positions, 981 increasing their positions, 911 reducing their positions, and 111 closing their positions.
127% more first-time investments, than exits
New positions opened: 252 | Existing positions closed: 111
98% more funds holding in top 10
Funds holding in top 10: 44 → 87 (+43)
21% more capital invested
Capital invested by funds: $90.1B → $109B (+$19.1B)
5% more funds holding
Funds holding: 2,391 → 2,502 (+111)
8% more repeat investments, than reductions
Existing positions increased: 981 | Existing positions reduced: 911
0.04% more ownership
Funds ownership: 75.9% → 75.94% (+0.04%)
2% less call options, than puts
Call options by funds: $1.7B | Put options by funds: $1.72B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$369M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$332M |
| 3 |
Goldman Sachs
New York
|
+$169M |
| 4 |
BlackRock
New York
|
+$155M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$129M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$375M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$269M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$182M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$131M |
| 5 |
State Street
Boston,
Massachusetts
|
-$131M |
AMGN Hedge Fund Activity: Q3 2023 in Review
2,502 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q3 2023, worth a combined $109B — up 21% from $90.1B a quarter earlier.
Buyers outnumbered sellers: 252 funds opened new AMGN positions and 111 closed out — a net gain of 141 holders — while 981 added to existing stakes and 911 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $369M. The largest seller was Franklin Resources, cutting an estimated $375M.
- 2,502 institutional investors held Amgen (AMGN) as of Q3 2023, up from 2,391 in Q2 2023.
- Funds reported $109B of Amgen stock for Q3 2023, up 21% quarter-over-quarter.
- 252 funds opened new Amgen positions in Q3 2023 and 111 closed out, a net change of +141 holders.
- The largest Amgen buyer in Q3 2023 was T. Rowe Price Associates, an estimated $369M added.
- The largest Amgen seller in Q3 2023 was Franklin Resources, an estimated $375M sold.
Based on aggregated 13F filings for Q3 2023.